Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

TGF beta Inhibitors

Santa Cruz Biotechnology now offers a broad range of TGF beta Inhibitors for use in various applications. TGF beta inhibitors are compounds that inhibit the activity of the Transforming Growth Factor-beta (TGF-β) pathway, which plays a crucial role in regulating cell growth, differentiation, and immune responses. In scientific research, these inhibitors are invaluable for studying the complex signaling networks involved in cell proliferation, apoptosis, and tissue remodeling. By modulating the TGF-β pathway, researchers can explore mechanisms underlying fibrosis, cancer progression, and cellular senescence, thereby gaining insights into fundamental biological processes and disease states. TGF beta inhibitors have also been instrumental in the development of new experimental models to study immune regulation and tissue homeostasis, providing a deeper understanding of how cellular environments can influence immune responses and disease progression. These inhibitors are frequently used in laboratory studies to dissect the role of TGF-β in various cellular contexts, from stem cell biology to the exploration of epithelial-mesenchymal transition (EMT), a key process in developmental biology and cancer metastasis. View detailed information on our available TGF beta Inhibitors by clicking on the product name.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibits the TGFβ type I receptor ALK5 kinase activity, which can prevent the phosphorylation of Smad proteins, downstream effectors in the TGFβ signaling pathway.

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

AEBSF hydrochloride is a potent serine protease inhibitor that selectively disrupts the activity of various proteases involved in TGF-beta signaling pathways. Its unique ability to form stable complexes with target enzymes alters their catalytic efficiency, thereby modulating proteolytic processes. This compound exhibits distinct binding kinetics, allowing for precise control over protease activity, which can significantly influence cellular signaling cascades and downstream biological responses.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$107.00
$156.00
4
(1)

Inhibits the kinase activity of TGFβ type I receptors ALK4, ALK5, and ALK7, which can reduce Smad phosphorylation and signaling.

TGF-β RI Kinase Inhibitor V

627536-09-8sc-203294
2 mg
$88.00
3
(1)

Targets TGFβ type I receptor kinase, which can lead to decreased TGFβ signaling through the disruption of Smad phosphorylation.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$213.00
$359.00
3
(1)

Inhibits TGFβ receptor I, potentially reducing Smad2/3 phosphorylation and subsequent transcriptional responses to TGFβ.

EW-7197

1352608-82-2sc-507465
5 mg
$345.00
(0)

Inhibits ALK5 kinase activity, which can prevent Smad2/3 phosphorylation and thus impair TGFβ signal transduction.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$202.00
$811.00
16
(1)

Blocks ALK4, ALK5, and ALK7 kinase activities, which can attenuate Smad phosphorylation and TGFβ signaling.

ALK5 Inhibitor II

446859-33-2sc-221234
sc-221234A
sc-221234B
sc-221234C
sc-221234D
sc-221234E
sc-221234F
1 mg
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$77.00
$153.00
$219.00
$663.00
$1248.00
$4382.00
$7850.00
8
(1)

Inhibits ALK5 kinase, which can lead to decreased Smad2/3 phosphorylation and downregulation of TGFβ signal transduction.

Pirfenidone

53179-13-8sc-203663
sc-203663A
10 mg
50 mg
$102.00
$416.00
6
(1)

Can modulate TGFβ signaling through downregulation of TGFβ expression, although its precise mechanism of action is not fully elucidated.

Tranilast

53902-12-8sc-200389
sc-200389A
sc-200389B
sc-200389C
10 mg
50 mg
1 g
5 g
$31.00
$103.00
$283.00
$978.00
2
(1)

Reduces the synthesis and release of TGFβ, which can result in decreased TGFβ signaling.